Start / The Effective Statistician – in association with PSI / Rwe and the fda part 1

The Effective Statistician – in association with PSI

RWE and the FDA (Part 1)

36 min • 19 september 2022

Interview with Josephine Wolfram

RWEs are dependent on actual patient reaction and response data collected through records provided by the healthcare agencies
RWEs are viewed differently by statisticians and the FDA which may create friction, especially in the process of having one medication submitted for approval and production.
and more...

Learn more about effective clinical trials based on dependable evidence and other topics that will help you in becoming an effective statistician. Listen to this episode and share this with your friends and colleagues!

References:

Senaste avsnitt

Replay: R vs SAS - which is the better tool in pharmaceutical research

11 augusti | 42 min

Replay: The Chimp Paradox

4 augusti | 42 min

Replay: Is data science something for you?

28 juli | 26 min

Replay: Things we would like to have known before we started with RWE

21 juli | 49 min

AI and Statistics Start-ups: Opportunities and Challenges

30 juni | 44 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00